Track Omega Therapeutics's receivables ($490K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Omega Therapeutics (OMGA) currently reports a receivables of $490K as of September 2024. That compares with $1.4M in the prior-year period — down 66.1% year over year. Use the charts on this page to explore Omega Therapeutics's receivables history and peer comparisons.
Omega Therapeutics's receivables decreased from $1.4M to $490K — a 66.1% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Omega Therapeutics reported $490K in receivables as of September 2024. That compares with $1.4M in the prior-year period — down 66.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $490K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Omega Therapeutics, and consider following OMGA for alerts when major investors trade the stock.
Omega Therapeutics is classified in the Healthcare sector. On receivables, it currently shows $490K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OMGA with unrelated industries.